Literature DB >> 11034993

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.

A M Mehl1, J E Floettmann, M Jones, P Brennan, M Rowe.   

Abstract

The latent membrane protein-1 (LMP1) of Epstein-Barr virus induces gene transcription, phenotypic changes, and oncogenic transformation. One cellular gene induced by LMP1 is that for intercellular adhesion molecule-1 (ICAM-1), which participates in a wide range of inflammatory and immune responses. ICAM-1 may enhance the immune recognition of cells transformed by Epstein-Barr virus, and thus combat development of malignancy. Despite growing understanding of the various signaling functions of LMP1, the molecular mechanisms by which LMP1 induces ICAM-1 are not understood. Here, we demonstrate that transcriptional activation by LMP1 is absolutely dependent upon a variant NF-kappaB motif within the tumor necrosis factor alpha (TNFalpha) response element of the ICAM-1 promoter. Although the TNFalpha response element is sufficient for TNFalpha induction of the ICAM-1 promoter, LMP1 also required the cooperation of additional upstream sequences for optimal induction. Inhibitor studies of known LMP1-induced signaling pathways ruled out the involvement of c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase, and the Janus-activating tyrosine kinase 3 (JAK3), and confirmed NF-kappaB as a critical factor for induction of ICAM-1. However, although constitutive activation of NF-kappaB efficiently induced promoter activity, it was not sufficient to induce either ICAM-1 mRNA or ICAM-1 protein. Using signaling defective LMP1 mutants and deacetylation inhibitors, we showed that the C-terminal activator region 1 of LMP1 delivers a new cooperating signal to induce ICAM-1 mRNA.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11034993     DOI: 10.1074/jbc.M003758200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Tyrosine phosphorylation of CD13 regulates inflammatory cell-cell adhesion and monocyte trafficking.

Authors:  Jaganathan Subramani; Mallika Ghosh; M Mamunur Rahman; Leslie A Caromile; Claire Gerber; Karim Rezaul; David K Han; Linda H Shapiro
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  LMP1 strain variants: biological and molecular properties.

Authors:  Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

4.  Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-κB signaling during productive replication.

Authors:  Shinichi Saito; Takayuki Murata; Teru Kanda; Hiroki Isomura; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

5.  LY294002 and rapamycin co-operate to inhibit T-cell proliferation.

Authors:  Elaine M Breslin; Paul C White; Angharad M Shore; Mathew Clement; Paul Brennan
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

6.  Herpesvirus saimiri STP-A oncoprotein utilizes Src family protein tyrosine kinase and tumor necrosis factor receptor-associated factors to elicit cellular signal transduction.

Authors:  Maria I Garcia; Joseph Kaserman; Young-Hwa Chung; Jae U Jung; Sun-Hwa Lee
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

7.  Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms.

Authors:  Stuart Prince; Sinead Keating; Ceri Fielding; Paul Brennan; Eike Floettmann; Martin Rowe
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.

Authors:  Maria Vaysberg; Olivia Hatton; Stacie L Lambert; Andrew L Snow; Bonnie Wong; Sheri M Krams; Olivia M Martinez
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

9.  The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.

Authors:  Sinéad Keating; Stuart Prince; Matthew Jones; Martin Rowe
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

Authors:  Brendan N D'Souza; Leonard C Edelstein; Pamela M Pegman; Sinéad M Smith; Sinéad T Loughran; Ann Clarke; Anja Mehl; Martin Rowe; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.